Supplementary protection
LT - Vaisto forma, skirta 3-[(2-{[4-heksiloksikarbonilamino-imino-metil)-fenilamino]-metil}-1-metil-1H-benzimidazol-5-karbonil)-piridin-2-il-amino]propiono rūgšties etilo esterio arba jo druskų peroraliniam vartojimui
EN - DOSAGE FORM FOR ORAL ADMINISTRATION OF 3-[(2-{[4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYL)-PHENYLAMINO]-METHYL}-1-METHYL-1H-BENZIMIDAZOL-5-CARBONYL)-PYRIDIN-2-YL-AMINO] PROPIONIC ACID ETHYL ESTER OR ITS SALTS
SPC
| (11) |
Number of the document |
|
| (68) |
Number of the document |
1485094
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2012 021 |
| (22) |
Date of filing the application |
2012-12-12 |
| (41) |
Date of publication of the application |
2013-01-25 |
|
Date of publication of SPC |
|
| (24) |
Date of coming into effect of SPC |
|
Applicant
| (71) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
Grantee
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/08/442/009 - EU/1/08/442/014, 2011-08-01
|
Name of the product protected by the basic patent
| (95) |
Dabigatranum etexilatum, mesylatum |
Legal status
|
SPC application withdrawn
|
|
